DRP Cancer Tests

ALLARITY MEDICAL LABORATORY

Available DRP Cancer Tests

Over the years, Allarity Medical Laboratory has developed a comprehensive range of Drug Response Predictors (DRPs) that can be applied by other organizations for investigational or research use.

These tools provide valuable insights into the effectiveness of specific drugs based on the gene expression signatures of patients’ tumors, and may aid the development of personalized medicine and targeted therapies.

Advanced Predictive Cancer Testing using DRP

The Drug Response Predictor (DRP®) is a proprietary diagnostic platform that analyzes transcriptional (RNA) changes in tumor cells in response to various drug types. It leverages gene expression data from over 3,000 patient tumors and millions of datapoints to identify patient responders and studied in more than 35 clinical trials across numerous cancer indications and drug types. Read more about the DRP here.

Available DRP Cancer Tests

Cancer Types Covered

Allarity has made research use only (RUO) drug response predictors (DRP) for the following 16 cancer types:

  • Breast
  • Ovarian
  • RCC (Renal Cell Carcinoma)
  • Prostate
  • Endometrial
  • NSCLC (Non-Small Cell Lung Cancer)
  • HCC (Hepatocellular Carcinoma)
  • Colon
  • Glioma
  • Esophagus
  • MDS (Myelodysplastic Syndromes)
  • AML (Acute Myeloid Leukemia)
  • ALL (Acute Lymphoblastic Leukemia)
  • CLL (Chronic Lymphocytic Leukemia)
  • Myeloma
  • DLBCL (Diffuse Large B-Cell Lymphoma)
Drugs Analyzed

In parallel, Allarity has developed RUO drug response predictors for the following drugs:

# Drug Regulatory Status Scientific Publications*
1 Afatinib RUO
2 Alectinib RUO
3 Anastrozole RUO
4 Ara-C RUO
5 Arsenic trioxide RUO
6 Asparaginase RUO
7 AS605240 RUO
8 Axitinib RUO
9 AZD6482 RUO
10 AZD8055 RUO
11 Belinostat RUO Link to publication
12 Bendamustine RUO
13 Bleomycin RUO
14 Bortezomib RUO Link to publication
15 Bosutinib RUO
16 Busulfan RUO
17 Cabozantinib RUO
18 Carfilzomib RUO
19 Carmustine RUO
20 Capecitabine RUO
21 Cetuximab RUO
22 Clofarabine RUO
23 Cobimetinib RUO
24 CP466722 RUO
25 Crizotinib RUO
26 CUDC-101 RUO
27 Cyclophosphamide RUO
28 CX-5461 RUO
29 Dacarbazine RUO
30 Dabrafenib RUO
31 Daratumumab RUO Link to publication
32 Dasatinib RUO
33 Daunorubicin RUO
34 Decitabine RUO
35 Depsipeptide RUO
36 Dexamethasone RUO
37 Docetaxel RUO
38 Dovitinib IUO Link to publication
39 Doxorubicin RUO Link to publication
40 Epirubicin RUO Link to publication
41 Eribulin RUO
42 Erlotinib RUO
43 Estramustine RUO
44 Etoposide RUO
45 Everolimus RUO
46 Exemestane RUO
47 Fedratinib RUO
48 Fludarabine RUO
49 Fulvestrant RUO Link to publication
50 Gemcitabine RUO
51 Hydroxyurea RUO
52 Ibrutinib RUO
53 Idarubicin RUO
54 Idelalisib RUO
55 Imatinib RUO
56 Iressa RUO
57 Irinotecan RUO
58 Irofulven RUO
59 Ixazomib RUO
60 Ixabepilone IUO
61 KU-55933 RUO
62 Lapatinib RUO
63 Lenalidomide RUO
64 Lenvatinib RUO
65 Lestaurtinib RUO
66 Leukeran RUO
67 Linifanib RUO
68 Lomustine RUO
69 Mechlorethamine RUO
70 Melphalan RUO Link to publication
71 Mercaptopurine RUO
72 Methotrexate RUO
73 Midostaurin RUO
74 Mitoxantrone RUO
75 Navitoclax RUO
76 Nilotinib RUO
77 Olaparib RUO
78 OSI-027 RUO
79 Oxaliplatin RUO
80 Paclitaxel RUO
81 Palbociclib RUO
82 Panobinostat RUO
83 Pazopanib RUO
84 Perifosine RUO
85 Pralatrexate RUO
86 Procarbazine RUO
87 Quizartinib RUO
88 Rapamycin RUO
89 Rucaparib RUO
90 Ruxolitinib RUO
91 Seliciclib RUO
92 Selumetinib RUO
93 Sepantronium RUO
94 Sorafenib RUO
95 TAE-684 RUO
96 Tamoxifen RUO
97 Tanespimycin RUO
98 Tarceva RUO
99 Temsirolimus RUO
100 Teniposide RUO
101 Thalidomide RUO
102 Thioguanine RUO
103 Thiotepa RUO
104 Tivozanib RUO
105 Trametinib RUO
106 Valrubicin RUO
107 Veliparib RUO
108 Vemurafenib RUO
109 Venetoclax RUO
110 Vinblastine RUO
111 Vincristine RUO
112 Vinorelbine RUO Link to publication
113 Vorinostat RUO
114 YK-4-279 RUO
115 QL-X-138 RUO
116 5-Fluorouracil RUO Link to publication
# Drug Regulatory Status Scientific Publications*
1 Afatinib RUO
2 Alectinib RUO
3 Anastrozole RUO
4 Ara-C RUO
5 Arsenic trioxide RUO
6 Asparaginase RUO
7 AS605240 RUO
8 Axitinib RUO
9 AZD6482 RUO
10 AZD8055 RUO
11 Belinostat RUO Link to publication
12 Bendamustine RUO
13 Bleomycin RUO
14 Bortezomib RUO Link to publication
15 Bosutinib RUO
16 Busulfan RUO
17 Cabozantinib RUO
18 Carfilzomib RUO
19 Carmustine RUO
20 Clofarabine RUO
21 Cobimetinib RUO
22 CP466722 RUO
23 Crizotinib RUO
24 CUDC-101 RUO
25 CX-5461 RUO
26 Dacarbazine RUO
27 Dabrafenib RUO
28 Dasatinib RUO
29 Daunorubicin RUO
30 Decitabine RUO
31 Depsipeptide RUO
32 Docetaxel RUO
33 Dovitinib IUO Link to publication
34 Doxorubicin RUO Link to publication
35 Epirubicin RUO Link to publication
36 Eribulin RUO
37 Erlotinib RUO
38 Estramustine RUO
39 Everolimus RUO
40 Exemestane RUO
41 Fedratinib RUO
42 Fludarabine RUO
43 Fulvestrant RUO Link to publication
44 Gemcitabine RUO
45 Hydroxyurea RUO
46 Ibrutinib RUO
47 Idarubicin RUO
48 Idelalisib RUO
49 Imatinib RUO
50 Iressa RUO
51 Irinotecan RUO Link to publication
52 Irofulven RUO
53 Ixazomib RUO
54